AEON Biopharma, Inc. (AEON): Depreciation & Amortization
$78.0K
Year ended 2025-12-31
$78.0K
Trailing 12 months to 2026-06-30
+4.7%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $78.0K | -19.6% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $97.0K | n/a | 2026-03-30, From 2024-01-01 |
| No annual figure between 2022-12-31 and 2024-12-31. | |||
| 2022-12-31 | $68.0K | n/a | 2024-05-14, From 2022-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $78.0K | -19.6% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $43.3K | +269.5% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $615.7K | -11.6% |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | $65.0K | -53.2% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2024-12-31 | $2.83M | -13.8% |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $200.9K | -40.5% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $138.1K | +5.2% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $68.8K | -27.9% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $219.0K | +6.3% |
Compare AEON, SXTP, QUCY, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗